7459:TSEMEDIPAL HOLDINGS Corporation Analysis

MediPal is trading at a price of 2,638 JPY, which sits below its 20‑day, 50‑day and 200‑day moving averages, indicating short‑term weakness. The RSI of 38.8 suggests the stock is approaching oversold territory, while the MACD histogram remains negative, confirming bearish momentum. Despite the technical softness, the stock’s PE ratio of 12.8 is well under the industry average of 24.8 and the price‑to‑book of 0.83 points to a valuation gap. A discounted cash‑flow model places fair value near 5,364 JPY, implying roughly a 10% upside from the current level, and analyst price targets cluster around 2,910‑2,912 JPY. The company enjoys a strong cash position of over 289 billion JPY and carries no debt, supporting a dividend yield of 2.58% with a comfortable payout ratio of 32%. Overall, the market sentiment is extremely bullish (Fear‑Greed Index 89.9), yet the technicals and valuation suggest a measured entry point.